<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fluorescence in situ hybridization (FISH) was performed in 17 myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> patients and seven <z:hpo ids='HP_0005526'>lymphoid leukemia</z:hpo>/ <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients who exhibited chromosomal abnormalities on the short arm of chromosome 17, in order to detect a commonly deleted region on chromosome band 17p13 </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-four <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients studied cytogenetically at our institution over a period of 10 years had detectable 17p abnormalities such as translocation (six patients), addition (11 patients) and deletion of 17p13 (seven patients) </plain></SENT>
<SENT sid="2" pm="."><plain>A 17p abnormality was the only abnormality present in three patients </plain></SENT>
<SENT sid="3" pm="."><plain>Most of the patients had additional complex cytogenetic abnormalities </plain></SENT>
<SENT sid="4" pm="."><plain>The diagnosis was <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) in 10 patients, two each with <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL), <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and the remaining three with malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (ML) </plain></SENT>
<SENT sid="5" pm="."><plain>Seven cosmid probes (D17S34, cCI17-624, cCI17-453, D17S379, cCI17-636, cCI17-732 and TP53) which mapped on 17p13 were used to analyze the allelic deletion </plain></SENT>
<SENT sid="6" pm="."><plain>Eighty percent (19 out of 24) of the informative <z:hpo ids='HP_0001909'>leukemia</z:hpo> patients exhibited allelic loss in 17p13.3 at cC17-624 </plain></SENT>
<SENT sid="7" pm="."><plain>The smallest region of an overlapping deletion was observed on chromosome band 17p13.3 between cCI17-624 and cCI17-453 </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with translocation involving 17p also showed deletion at cCI17-624 and cCI17-453 </plain></SENT>
<SENT sid="9" pm="."><plain>We hypothesize that this region contains a novel <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene(s) that is involved in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
</text></document>